Cargando…

Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering

Although bone is an organ that displays potential for self-healing after damage, bone regeneration does not occur properly in some cases, and it is still a challenge to treat large bone defects. The development of bone tissue engineering provides a new approach to the treatment of bone defects. Amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zha, Kangkang, Tian, Yue, Panayi, Adriana C., Mi, Bobin, Liu, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904963/
https://www.ncbi.nlm.nih.gov/pubmed/35281084
http://dx.doi.org/10.3389/fcell.2022.824812
_version_ 1784665076405370880
author Zha, Kangkang
Tian, Yue
Panayi, Adriana C.
Mi, Bobin
Liu, Guohui
author_facet Zha, Kangkang
Tian, Yue
Panayi, Adriana C.
Mi, Bobin
Liu, Guohui
author_sort Zha, Kangkang
collection PubMed
description Although bone is an organ that displays potential for self-healing after damage, bone regeneration does not occur properly in some cases, and it is still a challenge to treat large bone defects. The development of bone tissue engineering provides a new approach to the treatment of bone defects. Among various cell types, mesenchymal stem cells (MSCs) represent one of the most promising seed cells in bone tissue engineering due to their functions of osteogenic differentiation, immunomodulation, and secretion of cytokines. Regulation of osteogenic differentiation of MSCs has become an area of extensive research over the past few years. This review provides an overview of recent research progress on enhancement strategies for MSC osteogenesis, including improvement in methods of cell origin selection, culture conditions, biophysical stimulation, crosstalk with macrophages and endothelial cells, and scaffolds. This is favorable for further understanding MSC osteogenesis and the development of MSC-based bone tissue engineering.
format Online
Article
Text
id pubmed-8904963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89049632022-03-10 Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering Zha, Kangkang Tian, Yue Panayi, Adriana C. Mi, Bobin Liu, Guohui Front Cell Dev Biol Cell and Developmental Biology Although bone is an organ that displays potential for self-healing after damage, bone regeneration does not occur properly in some cases, and it is still a challenge to treat large bone defects. The development of bone tissue engineering provides a new approach to the treatment of bone defects. Among various cell types, mesenchymal stem cells (MSCs) represent one of the most promising seed cells in bone tissue engineering due to their functions of osteogenic differentiation, immunomodulation, and secretion of cytokines. Regulation of osteogenic differentiation of MSCs has become an area of extensive research over the past few years. This review provides an overview of recent research progress on enhancement strategies for MSC osteogenesis, including improvement in methods of cell origin selection, culture conditions, biophysical stimulation, crosstalk with macrophages and endothelial cells, and scaffolds. This is favorable for further understanding MSC osteogenesis and the development of MSC-based bone tissue engineering. Frontiers Media S.A. 2022-02-23 /pmc/articles/PMC8904963/ /pubmed/35281084 http://dx.doi.org/10.3389/fcell.2022.824812 Text en Copyright © 2022 Zha, Tian, Panayi, Mi and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Zha, Kangkang
Tian, Yue
Panayi, Adriana C.
Mi, Bobin
Liu, Guohui
Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering
title Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering
title_full Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering
title_fullStr Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering
title_full_unstemmed Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering
title_short Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering
title_sort recent advances in enhancement strategies for osteogenic differentiation of mesenchymal stem cells in bone tissue engineering
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904963/
https://www.ncbi.nlm.nih.gov/pubmed/35281084
http://dx.doi.org/10.3389/fcell.2022.824812
work_keys_str_mv AT zhakangkang recentadvancesinenhancementstrategiesforosteogenicdifferentiationofmesenchymalstemcellsinbonetissueengineering
AT tianyue recentadvancesinenhancementstrategiesforosteogenicdifferentiationofmesenchymalstemcellsinbonetissueengineering
AT panayiadrianac recentadvancesinenhancementstrategiesforosteogenicdifferentiationofmesenchymalstemcellsinbonetissueengineering
AT mibobin recentadvancesinenhancementstrategiesforosteogenicdifferentiationofmesenchymalstemcellsinbonetissueengineering
AT liuguohui recentadvancesinenhancementstrategiesforosteogenicdifferentiationofmesenchymalstemcellsinbonetissueengineering